MGLIX | VGSCX | MGLIX / VGSCX | |
Total Expense Ratio | 0.94 | 1.99 | 47% |
Annual Report Gross Expense Ratio | 0.95 | 2.16 | 44% |
Fund Existence | 17 years | 17 years | - |
Gain YTD | 4.988 | 9.890 | 50% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.26B | 391M | 579% |
Annual Yield % from dividends | 2.48 | 1.33 | 186% |
Returns for 1 year | -4.71 | 1.11 | -425% |
Returns for 3 years | 15.95 | 31.57 | 51% |
Returns for 5 years | 10.98 | 28.18 | 39% |
Returns for 10 years | 32.94 | 44.44 | 74% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 75.17 | 0.46 | +0.62% |
Janus Henderson Global Life Sciences T | |||
SSRRX | 6.71 | 0.03 | +0.45% |
Touchstone Small Company R6 | |||
GMVRX | 16.40 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity R | |||
ABALX | 39.02 | 0.05 | +0.13% |
American Funds American Balanced A | |||
SGQIX | 46.28 | -0.03 | -0.06% |
DWS International Growth Inst |